Parents’ Confusion Leads FDA To Repeat Advisory On Cough/Cold OTCs
This article was originally published in The Tan Sheet
Executive Summary
Recent survey results showing confusion among parents about the safety of using OTC cough/cold products in young children prompted FDA to re-issue a warning that the drugs are inappropriate for children under 2, Office of Nonprescription Product officials said Jan. 17
You may also be interested in...
FDA Gets Strict On Liquid OTC Dosing Devices In Draft Guidance
Some drug firms may need to alter their product packaging and labeling to comply with FDA's guidance on dosing device labeling for liquid OTCs
FDA Gets Strict On Liquid OTC Dosing Devices In Draft Guidance
Some drug firms may need to alter their product packaging and labeling to comply with FDA's guidance on dosing device labeling for liquid OTCs
FDA Gets Strict On Liquid OTC Dosing Devices In Draft Guidance
Some drug firms may need to alter their product packaging and labeling to comply with FDA's guidance on dosing device labeling for liquid OTCs